Crossref journal-article
Elsevier BV
Immunity (78)
Bibliography

Hanada, T., Yoshida, H., Kato, S., Tanaka, K., Masutani, K., Tsukada, J., Nomura, Y., Mimata, H., Kubo, M., & Yoshimura, A. (2003). Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity. Immunity, 19(3), 437–450.

Authors 10
  1. Toshikatsu Hanada (first)
  2. Hiroki Yoshida (additional)
  3. Seiya Kato (additional)
  4. Kentaro Tanaka (additional)
  5. Kohsuke Masutani (additional)
  6. Jun Tsukada (additional)
  7. Yoshio Nomura (additional)
  8. Hiromitsu Mimata (additional)
  9. Masato Kubo (additional)
  10. Akihiko Yoshimura (additional)
References 45 Referenced 175
  1. 10.1016/S0092-8674(00)80047-1 / Cell / SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine by Alexander (1999)
  2. 10.4049/jimmunol.167.4.2361 / J. Immunol. / Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus by Arce (2001)
  3. 10.1084/jem.20020619 / J. Exp. Med. / A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis by Atsumi (2002)
  4. 10.1172/JCI750 / J. Clin. Invest. / Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice by Balomenos (1998)
  5. 10.1126/science.1064890 / Science / Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus by Blanco (2001)
  6. 10.1038/11360 / Nat. Med. / Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon by Cella (1999)
  7. 10.1111/j.1600-065X.1999.tb01310.x / Immunol. Rev. / The central and multiple roles of B cells in lupus pathogenesis by Chan (1999)
  8. 10.1016/S1074-7613(03)00078-5 / Immunity / Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation by Chong (2003)
  9. 10.1111/j.1749-6632.1988.tb27079.x / Ann. N Y Acad. Sci. / B-cell compartment in the thymus of patients with myasthenia gravis and control subjects by Christensson (1988)
  10. 10.4049/jimmunol.165.4.1799 / J. Immunol. / Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice by Fujimoto (2000)
  11. 10.1038/ni825 / Nat. Immunol. / PI3K-mediated negative feedback regulation of IL-12 production in DCs by Fukao (2002)
  12. {'key': '10.1016/S1074-7613(03)00240-1_BIB12', 'first-page': '1621', 'article-title': 'Induction of systemic lupus erythematosus by interferon-γ in a patient with rheumatoid arthritis', 'volume': '18', 'author': 'Graninger', 'year': '1991', 'journal-title': 'J. Rheumatol.'} / J. Rheumatol. / Induction of systemic lupus erythematosus by interferon-γ in a patient with rheumatoid arthritis by Graninger (1991)
  13. 10.1038/35010115 / Nature / TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease by Gross (2000)
  14. 10.4049/jimmunol.160.8.3713 / J. Immunol. / IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice by Haas (1998)
  15. 10.1074/jbc.M106139200 / J. Biol. Chem. / A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box by Hanada (2001)
  16. 10.1084/jem.193.12.1393 / J. Exp. Med. / Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC by Ishikawa (2001)
  17. 10.1016/S1074-7613(02)00425-9 / Immunity / BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2 by Kayagaki (2002)
  18. 10.1016/S1074-7613(02)00446-6 / Immunity / SOCS1/JAB is a negative regulator of LPS-induced macrophage activation by Kinjyo (2002)
  19. 10.1038/ni829 / Nat. Immunol. / DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL by Litinskiy (2002)
  20. 10.1016/S0022-1759(98)00204-X / J. Immunol. Methods / An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow by Lutz (1999)
  21. 10.1016/S1074-7613(02)00398-9 / Immunity / Dendritic cells, BAFF, and APRIL by MacLennan (2002)
  22. 10.1038/nri844 / Nat. Rev. Immunol. / Baff by Mackay (2002)
  23. 10.1046/j.1440-1711.2002.01115.x / Immunol. Cell Biol. / Immature, but not inactive by Mahnke (2002)
  24. 10.1016/S0092-8674(00)80048-3 / Cell / SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality by Marine (1999)
  25. 10.1073/pnas.022628499 / Proc. Natl. Acad. Sci. USA / Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1) by Metcalf (2002)
  26. 10.1038/416865a / Nature / Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C-delta by Miyamoto (2002)
  27. 10.1126/science.285.5425.260 / Science / Blys by Moore (1999)
  28. 10.1016/S0304-3835(02)00244-6 / Cancer Lett. / Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas by Nagai (2002)
  29. 10.1016/S1074-7613(01)00132-7 / Immunity / SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo by Naka (2001)
  30. 10.1016/S1074-7613(02)00449-1 / Immunity / SOCS-1 participates in negative regulation of LPS responses by Nakagawa (2002)
  31. 10.4049/jimmunol.165.10.5970 / J. Immunol. / Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus by Odendahl (2000)
  32. 10.1046/j.1440-1711.2002.01112.x / Immunol. Cell Biol. / The interplay of dendritic cell subsets in systemic lupus erythematosus by Palucka (2002)
  33. 10.1172/JCI119361 / J. Clin. Invest. / Roles of interferon-γ and interleukin-4 in murine lupus by Peng (1997)
  34. 10.1111/j.1365-2796.1990.tb00144.x / J. Intern. Med. / Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour by Ronnblom (1990)
  35. 10.1084/jem.183.6.2675 / J. Exp. Med. / Protection against lethal toxic shock by targeted disruption of the CD28 gene by Saha (1996)
  36. 10.1182/blood.V92.5.1668 / Blood / A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons by Sakamoto (1998)
  37. 10.4049/jimmunol.161.1.494 / J. Immunol. / IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice by Schwarting (1998)
  38. 10.1084/jem.186.9.1451 / J. Exp. Med. / Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon γ in the epidermis by Seery (1997)
  39. 10.1172/JCI13568 / J. Clin. Invest. / Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis by Shouda (2001)
  40. 10.1126/science.284.5421.1835 / Science / The nature of the principal type 1 interferon-producing cells in human blood by Siegal (1999)
  41. 10.1073/pnas.231606698 / Proc. Natl. Acad. Sci. USA / Avoiding horror autotoxicus by Steinman (2002)
  42. 10.3109/10520299609117157 / Biotech. Histochem. / Age associated changes in the distribution of lpr gene-induced B220-positive T cells in lymphoid organs of MRL/Mp-lpr/lpr mice using dual exposure microphotographs of double immunofluorescence staining by Usui (1996)
  43. 10.1016/S1074-7613(01)00201-1 / Immunity / Delineating the genetic basis of systemic lupus erythematosus by Wakeland (2001)
  44. 10.1093/emboj/18.5.1309 / EMBO J. / The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop by Yasukawa (1999)
  45. 10.1038/ng0501-29 / Nat. Genet. / SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity by Yoshikawa (2001)
Dates
Type When
Created 21 years, 4 months ago (April 15, 2004, 5:36 a.m.)
Deposited 2 years, 4 months ago (April 28, 2023, 4:02 a.m.)
Indexed 5 hours, 30 minutes ago (Sept. 6, 2025, 4:21 p.m.)
Issued 22 years ago (Sept. 1, 2003)
Published 22 years ago (Sept. 1, 2003)
Published Print 22 years ago (Sept. 1, 2003)
Funders 5
  1. Uehara Memorial Foundation 10.13039/100008732

    Region: Asia

    pri (Trusts, charities, foundations (both public and private))

    Labels4
    1. The Uehara Memorial Foundation
    2. Uehara Memorial Life Science Foundation
    3. 上原記念生命科学財団
    4. UMF
  2. Human Frontier Science Program 10.13039/501100000854

    Region: Europe

    pri (International organizations)

    Labels1
    1. HFSP
  3. Japan Health Sciences Foundation 10.13039/100007416

    Region: Asia

    pri (Trusts, charities, foundations (both public and private))

    Labels1
    1. JHSF
  4. Japan Research Foundation for Clinical Pharmacology 10.13039/100008728
  5. Ministry of Education, Culture, Sports, Science and Technology 10.13039/501100001700

    Region: Asia

    gov (National government)

    Labels3
    1. Monbu-kagaku-shō
    2. 文部科学省
    3. MEXT

@article{Hanada_2003, title={Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity}, volume={19}, ISSN={1074-7613}, url={http://dx.doi.org/10.1016/s1074-7613(03)00240-1}, DOI={10.1016/s1074-7613(03)00240-1}, number={3}, journal={Immunity}, publisher={Elsevier BV}, author={Hanada, Toshikatsu and Yoshida, Hiroki and Kato, Seiya and Tanaka, Kentaro and Masutani, Kohsuke and Tsukada, Jun and Nomura, Yoshio and Mimata, Hiromitsu and Kubo, Masato and Yoshimura, Akihiko}, year={2003}, month=sep, pages={437–450} }